Part Number : NDC00409-6779-02 | Manufacturer : Hospira Inc | ||
NSN : 6505-01-650-2654 (6505016502654) | |||
Item Name : Lorazepam Injection Usp | CAGE Code : 3VBU6 | ||
NIIN : 01-650-2654 (016502654) | |||
INC Code : 50832 | |||
NCB Code : 01 | Country : USA | ||
Alternate P/N: NDC00409677902 |
Thank you for taking an interest in part number NDC00409-6779-02, that of which is listed with the description Lorazepam Injection Usp; Manufactured by Hospira Inc and listed alongside the NSN 6505016502654, part number NDC00409-6779-02 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
Part Number : NDC00409-6779-02 | Manufacturer : Hospira Inc | ||
NSN Number : 6505-01-650-2654 (6505016502654) | |||
Item Name : Lorazepam Injection Usp | CAGE Code : 3VBU6 | ||
NIIN : 016502654 |
Thank you for taking an interest in part number NDC00409-6779-02, that of which is listed with the description Lorazepam Injection Usp; Manufactured by Hospira Inc and listed alongside the NSN 6505016502654, part number NDC00409-6779-02 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
---|---|---|---|---|---|---|
6505-01-650-2654 Item PartTypeName: LORAZEPAM INJECTION | 6505 | 016502654 | M | P | ||
CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
Q | A | 0 | ||||
Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
6505NCM152485 | 5 | 1 | 5 |
MRC | Criteria | Characteristic |
---|---|---|
AJCN | III PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 4.0 MILLIGRAMS LORAZEPAM PER MILLILITER |
AKJQ | PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
CQCT | PRIMARY CONTAINER TYPE | VIAL |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 2.0 MILLILITERS |
CRYC | III CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE IV |
CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
CSGS | ADMINISTRATION | INTRAVENOUS AND INTRAMUSCULAR |
CXCY | III PART NAME ASSIGNED BY CONTROLLING AGENCY | ATIVAN 4 MG/ML 1 ML VIAL 10 VIALS PER PACKAGE |
FEAT | SPECIAL FEATURES | FOR INTRAVENOUS OR INTRAMUSCULAR ADMINISTRATION; DEA CONTROLLED SUBSTANCE CLASS IV; CONCENTRATION/STRENGTH/TOTAL CONTENT: 4 MG /ML; FILL IN: 1 ML; SIZE: 2 ML; EACH ML CONTAINS 4 MILLIGRAMS OF LORAZEPAM; PROTECT FROM LIGHT; STORE IN A REFRIG |
We hope that you will visit us again the next time you need board-level components, aviation and aerospace parts, and more. Allow us to serve as your strategic purchasing partner.
Request for Quote